Annual Total Expenses
$13.83 M
+$2.61 M+23.26%
October 1, 2024
Summary
- As of February 8, 2025, ANIX annual total expenses is $13.83 million, with the most recent change of +$2.61 million (+23.26%) on October 1, 2024.
- During the last 3 years, ANIX annual total expenses has risen by +$183.00 thousand (+1.34%).
- ANIX annual total expenses is now -6.66% below its all-time high of $14.82 million, reached on October 31, 2018.
Performance
ANIX Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$3.16 M
-$429.00 K-11.94%
October 1, 2024
Summary
- As of February 8, 2025, ANIX quarterly total expenses is $3.16 million, with the most recent change of -$429.00 thousand (-11.94%) on October 1, 2024.
- Over the past year, ANIX quarterly total expenses has increased by +$112.00 thousand (+3.67%).
- ANIX quarterly total expenses is now -47.00% below its all-time high of $5.97 million, reached on July 31, 2018.
Performance
ANIX Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
ANIX Total Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +23.3% | +3.7% |
3 y3 years | +1.3% | +11.2% |
5 y5 years | +18.0% | +11.2% |
ANIX Total Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -0.3% | +23.3% | -18.5% | +23.8% |
5 y | 5-year | -0.3% | +38.6% | -27.9% | +41.1% |
alltime | all time | -6.7% | +963.9% | -47.0% | +954.3% |
Anixa Biosciences Total Expenses History
Date | Annual | Quarterly |
---|---|---|
Oct 2024 | $13.83 M(+23.3%) | $3.16 M(-11.9%) |
Jul 2024 | - | $3.59 M(+3.6%) |
Apr 2024 | - | $3.47 M(-3.9%) |
Jan 2024 | - | $3.61 M(+18.3%) |
Oct 2023 | $11.22 M(-19.1%) | $3.05 M(+7.3%) |
Jul 2023 | - | $2.84 M(+2.7%) |
Apr 2023 | - | $2.77 M(+8.4%) |
Jan 2023 | - | $2.56 M(-29.2%) |
Oct 2022 | $13.88 M(+1.7%) | $3.61 M(+29.0%) |
Jul 2022 | - | $2.80 M(-22.1%) |
Apr 2022 | - | $3.59 M(-7.5%) |
Jan 2022 | - | $3.88 M(-4.8%) |
Oct 2021 | $13.65 M(+36.8%) | $4.08 M(-7.1%) |
Jul 2021 | - | $4.39 M(+80.1%) |
Apr 2021 | - | $2.44 M(-11.3%) |
Jan 2021 | - | $2.75 M(+22.5%) |
Oct 2020 | $9.98 M(-14.9%) | $2.24 M(-8.0%) |
Jul 2020 | - | $2.44 M(-8.8%) |
Apr 2020 | - | $2.67 M(+1.5%) |
Jan 2020 | - | $2.63 M(+23.6%) |
Oct 2019 | $11.72 M(-20.9%) | $2.13 M(-2.6%) |
Jul 2019 | - | $2.18 M(-23.2%) |
Apr 2019 | - | $2.84 M(-37.7%) |
Jan 2019 | - | $4.57 M(-5.4%) |
Oct 2018 | $14.82 M(+130.2%) | $4.82 M(-19.2%) |
Jul 2018 | - | $5.97 M(+177.5%) |
Apr 2018 | - | $2.15 M(+14.7%) |
Jan 2018 | - | $1.87 M(+7.9%) |
Oct 2017 | $6.44 M(+33.9%) | $1.74 M(-17.0%) |
Jul 2017 | - | $2.09 M(+72.7%) |
Apr 2017 | - | $1.21 M(-13.1%) |
Jan 2017 | - | $1.40 M(+25.3%) |
Oct 2016 | $4.81 M(-52.9%) | $1.11 M(+3.6%) |
Jul 2016 | - | $1.07 M(-6.4%) |
Apr 2016 | - | $1.15 M(-22.0%) |
Jan 2016 | - | $1.47 M(+25.0%) |
Oct 2015 | $10.20 M(+17.1%) | $1.18 M(-25.7%) |
Jul 2015 | - | $1.59 M(-26.5%) |
Apr 2015 | - | $2.16 M(-59.1%) |
Jan 2015 | - | $5.28 M(+79.6%) |
Oct 2014 | $8.71 M(+4.9%) | $2.94 M(+118.2%) |
Jul 2014 | - | $1.35 M(-45.3%) |
Apr 2014 | - | $2.46 M(+25.2%) |
Jan 2014 | - | $1.96 M(-9.2%) |
Oct 2013 | $8.31 M(+63.7%) | $2.16 M(-2.5%) |
Jul 2013 | - | $2.22 M(+19.9%) |
Apr 2013 | - | $1.85 M(-10.7%) |
Jan 2013 | - | $2.07 M(+20.6%) |
Oct 2012 | $5.07 M(-15.9%) | $1.72 M(+92.5%) |
Jul 2012 | - | $892.80 K(-20.7%) |
Apr 2012 | - | $1.13 M(-15.7%) |
Jan 2012 | - | $1.34 M(-8.2%) |
Oct 2011 | $6.03 M(+0.9%) | $1.46 M(-12.2%) |
Jul 2011 | - | $1.66 M(+20.6%) |
Apr 2011 | - | $1.37 M(-10.9%) |
Jan 2011 | - | $1.54 M(+7.3%) |
Oct 2010 | $5.98 M(-28.6%) | $1.44 M(+8.3%) |
Jul 2010 | - | $1.33 M(-20.1%) |
Apr 2010 | - | $1.66 M(+7.3%) |
Jan 2010 | - | $1.55 M(-55.6%) |
Oct 2009 | $8.38 M(+4.0%) | $3.49 M(+63.1%) |
Jul 2009 | - | $2.14 M(+30.4%) |
Apr 2009 | - | $1.64 M(-6.6%) |
Jan 2009 | - | $1.76 M(+14.0%) |
Oct 2008 | $8.05 M(+41.6%) | $1.54 M(-5.1%) |
Jul 2008 | - | $1.62 M(-24.3%) |
Apr 2008 | - | $2.14 M(-21.9%) |
Jan 2008 | - | $2.74 M(+159.4%) |
Oct 2007 | $5.69 M(-30.1%) | $1.06 M(-10.1%) |
Jul 2007 | - | $1.18 M(-23.4%) |
Apr 2007 | - | $1.54 M(-19.7%) |
Jan 2007 | - | $1.91 M(-0.3%) |
Oct 2006 | $8.14 M | $1.92 M(-16.1%) |
Date | Annual | Quarterly |
---|---|---|
Jul 2006 | - | $2.29 M(-8.2%) |
Apr 2006 | - | $2.49 M(+72.8%) |
Jan 2006 | - | $1.44 M(+20.3%) |
Oct 2005 | $4.91 M(+27.1%) | $1.20 M(-4.5%) |
Jul 2005 | - | $1.26 M(+1.9%) |
Apr 2005 | - | $1.23 M(+0.9%) |
Jan 2005 | - | $1.22 M(+27.1%) |
Oct 2004 | $3.86 M(+14.8%) | $960.70 K(-23.2%) |
Jul 2004 | - | $1.25 M(+56.9%) |
Apr 2004 | - | $797.70 K(-6.1%) |
Jan 2004 | - | $849.30 K(+15.0%) |
Oct 2003 | $3.36 M(-60.4%) | $738.30 K(+0.5%) |
Jul 2003 | - | $734.80 K(-26.0%) |
Apr 2003 | - | $992.70 K(+10.6%) |
Jan 2003 | - | $897.60 K(-78.0%) |
Oct 2002 | $8.50 M(+60.4%) | $4.08 M(+177.7%) |
Jul 2002 | - | $1.47 M(-15.1%) |
Apr 2002 | - | $1.73 M(+41.6%) |
Jan 2002 | - | $1.22 M(-17.0%) |
Oct 2001 | $5.29 M(-19.2%) | $1.47 M(-0.0%) |
Jul 2001 | - | $1.47 M(+42.1%) |
Apr 2001 | - | $1.04 M(-21.3%) |
Jan 2001 | - | $1.32 M(-26.8%) |
Oct 2000 | $6.56 M(-21.0%) | $1.80 M(+20.7%) |
Jul 2000 | - | $1.49 M(-9.6%) |
Apr 2000 | - | $1.65 M(-3.1%) |
Jan 2000 | - | $1.70 M(-46.9%) |
Oct 1999 | $8.30 M(+15.3%) | $3.20 M(+60.0%) |
Jul 1999 | - | $2.00 M(+25.0%) |
Apr 1999 | - | $1.60 M(+14.3%) |
Jan 1999 | - | $1.40 M(-17.6%) |
Oct 1998 | $7.20 M(+12.5%) | $1.70 M(-5.6%) |
Jul 1998 | - | $1.80 M(-5.3%) |
Apr 1998 | - | $1.90 M(-5.0%) |
Jan 1998 | - | $2.00 M(+33.3%) |
Oct 1997 | $6.40 M(+4.9%) | $1.50 M(-6.3%) |
Jul 1997 | - | $1.60 M(-11.1%) |
Apr 1997 | - | $1.80 M(+12.5%) |
Jan 1997 | - | $1.60 M(-23.8%) |
Oct 1996 | $6.10 M(+79.4%) | $2.10 M(+23.5%) |
Jul 1996 | - | $1.70 M(+54.5%) |
Apr 1996 | - | $1.10 M(0.0%) |
Jan 1996 | - | $1.10 M(0.0%) |
Oct 1995 | $3.40 M(-8.1%) | $1.10 M(+22.2%) |
Jul 1995 | - | $900.00 K(+12.5%) |
Apr 1995 | - | $800.00 K(+14.3%) |
Jan 1995 | - | $700.00 K(-12.5%) |
Oct 1994 | $3.70 M(+27.6%) | $800.00 K(-11.1%) |
Jul 1994 | - | $900.00 K(0.0%) |
Apr 1994 | - | $900.00 K(-25.0%) |
Jan 1994 | - | $1.20 M(+50.0%) |
Oct 1993 | $2.90 M(+45.0%) | $800.00 K(+33.3%) |
Jul 1993 | - | $600.00 K(-25.0%) |
Apr 1993 | - | $800.00 K(+33.3%) |
Jan 1993 | - | $600.00 K(+20.0%) |
Oct 1992 | $2.00 M(+33.3%) | $500.00 K(0.0%) |
Jul 1992 | - | $500.00 K(0.0%) |
Apr 1992 | - | $500.00 K(+25.0%) |
Jan 1992 | - | $400.00 K(0.0%) |
Oct 1991 | $1.50 M(0.0%) | $400.00 K(+33.3%) |
Jul 1991 | - | $300.00 K(-25.0%) |
Apr 1991 | - | $400.00 K(0.0%) |
Jan 1991 | - | $400.00 K(0.0%) |
Oct 1990 | $1.50 M(+15.4%) | $400.00 K(+33.3%) |
Jul 1990 | - | $300.00 K(-25.0%) |
Apr 1990 | - | $400.00 K(0.0%) |
Jan 1990 | - | $400.00 K |
Oct 1989 | $1.30 M(-7.1%) | - |
Oct 1988 | $1.40 M(0.0%) | - |
Oct 1987 | $1.40 M(-26.3%) | - |
Oct 1986 | $1.90 M(-5.0%) | - |
Oct 1985 | $2.00 M(0.0%) | - |
Oct 1984 | $2.00 M | - |
FAQ
- What is Anixa Biosciences annual total expenses?
- What is the all time high annual total expenses for Anixa Biosciences?
- What is Anixa Biosciences annual total expenses year-on-year change?
- What is Anixa Biosciences quarterly total expenses?
- What is the all time high quarterly total expenses for Anixa Biosciences?
- What is Anixa Biosciences quarterly total expenses year-on-year change?
What is Anixa Biosciences annual total expenses?
The current annual total expenses of ANIX is $13.83 M
What is the all time high annual total expenses for Anixa Biosciences?
Anixa Biosciences all-time high annual total expenses is $14.82 M
What is Anixa Biosciences annual total expenses year-on-year change?
Over the past year, ANIX annual total expenses has changed by +$2.61 M (+23.26%)
What is Anixa Biosciences quarterly total expenses?
The current quarterly total expenses of ANIX is $3.16 M
What is the all time high quarterly total expenses for Anixa Biosciences?
Anixa Biosciences all-time high quarterly total expenses is $5.97 M
What is Anixa Biosciences quarterly total expenses year-on-year change?
Over the past year, ANIX quarterly total expenses has changed by +$112.00 K (+3.67%)